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EXAMINATION OF REPLICATION
DYNAMICS IN FRAGILE SITES 		
		
THROUGH MOLECULAR COMBING
Shahana Ahmed Chumki
Dr. Anne Casper, Mentor
ABSTRACT
Chromosomal fragile sites are specific loci that exhibit instability visible as gaps and breaks on the chromosome following
inhibition of DNA synthesis and are generally categorized into two
main classes: rare fragile sites (RFSs) and common fragile sites
(CFSs). Under standard conditions, CFSs are typically stable but
are prone to breakage in cells subjected to replication stress. In recent years, their role in the generation of gross chromosome rearrangements has become increasingly evident, and fragile sites have
now connected to chromosome instability in cancer cells. The connection between CFSs and cancer thus highlights the importance of
the regulation of DNA replication to prevent cancer development.
The study of fragile sites in the yeast model organism has provided
insight into the mechanisms that lead to breakage and genome instability. Through the process of molecular combing, replication
dynamics can be observed at fragile sites to further understand the
consequence of replication stress on DNA damage.

LITERATURE REVIEW
Vast improvements in biomedical research have increased
our understanding of life’s many diseases and disorders. Developments in antibiotics and experimental medicines alone have statistically decimated communicable diseases (16), yet as humankind
slowly discovers the solution to one problem, another emerges.
Cancer has become one of society’s greatest burdens and is now
responsible for one in eight deaths worldwide (16). It is a genetic
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disease, caused by the ill effects of genomic damage in the DNA
of otherwise non-cancerous cells, and originates in most of the
cell types and organs of the human body (16). The cells themselves are characterized by relatively unrestrained proliferation
that can invade beyond normal tissue boundaries and metastasize
to distant organs (16).
Though the term encompasses a large pool of diseases, all
cancers are thought to share a common pathogenesis (16). Analogous to Darwinian evolution, cancer development is based on two
constituent processes: (1) the continuous genetic variation in individual cells by more-or-less random mutation, and (2) natural selection acting on the resultant phenotypic diversity (16). Selection
may have the ability to weed out many of the deleterious mutations or foster cells carrying alteration that can emerge as invisible
and benign cell growth (16). However, occasionally cancer growth
emerges when DNA replication of cells incurs genetic damage and
allows an advantageous mutation to proliferate autonomously, invade cells, and metastasize (16).

I. DNA Replication
Replication of the eukaryotic genome is a difficult task,
as cells must coordinate chromosome replication with chromatin
remodeling, DNA recombination, DNA repair, and transcription
cell cycle progression (12). This process is initiated in multiple
steps along the chromosome by origins of replication (1). Studies have shown that replicating origins are first licensed during
the G1 phase of the cell cycle through the stepwise assembly of
pre-replication complexes (pre-RC) (1)(2). Cells are then initiated
into the S phase of mitosis, where DNA replication occurs. Replication forks and origins are controlled by specific mechanisms to
ensure they are activated once, and only once, per cell cycle (1)
(2). Despite its many reparative functions in the face of mutations
and mistakes, DNA replication can be a genotoxic process (12).
Even though the process should be as reliable as possible
in order to minimize mutations, DNA replication in some regions
of the genome appears to raise speciﬁc problems (10). At these
regions, DNA replication forks frequently slow down or even stall
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when encountering obstacles in their way, such as repetitive sequences or secondary structures (12). Most of the time, the stalled
forks can easily resume synthesis after the block; however, these
regions of the chromosome lead to fork collapse and accumulate
abnormal DNA intermediates such as long stretches of single
stranded DNA (ssDNA) or DNA breaks or gaps (12). Breaks and
additional structures can prevent fork restart and cause cell lethality or genome deletions that can lead to instability (12).
Genetic instability and deletions in cancer genomes occasionally occur over chromosomal fragile sites, where they are thought
to reflect an increased local rate of DNA breakage (3). Fragile sites
are regions of the chromosome where inhibition of DNA replication
can lead to gaps and breaks, and several fragile sites are located at
or near tumor suppressor genes (6). Mutations in such genes that encode the proteins that control the cell cycle are extremely common in
cancer cells and lead to no detection of incorrect growth and to the
abortion of replication in the instance of damaged DNA (3). Thus it is
thought that some tumor suppressor genes become deactivated due to
chromosome breakage at fragile sites (16).

II. Fragile Sites
Chromosomal fragile sites are specific loci that preferentially exhibit chromosome instability, visible as gaps and breaks
on the chromosome following partial inhibition of DNA replication (6). The study of human fragile sites has led to identification
of diseases such as fragile X syndrome and trinucleotide repeat
expansions (6). Fragile sites are generally categorized into two
main classes: rare fragile sites (RFSs) and common fragile sites
(CFSs) (6). Rare fragile sites (RFS) are uncommon in the human
genome because they result from mutation, and they segregate in
a Mendelian manner (6). RFSs are the result of expansions in triand dinucleotide repeats that allow for the formation of secondary
structures, leading to fragility during replication (6). In the clinical
context, some rare fragile sites are linked with conditions causing
mental retardation, such as Fragile X syndrome (FRAXA) and Jacobsen syndrome (FRA11B) (6).
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In contrast, common fragile sites (CFSs) are present in all
individuals and are a component of normal chromosome structure
(6). Under standard conditions, CFSs are typically stable, but they
are prone to breakage in cells subjected to replication stress, particularly under low levels of DNA polymerase alpha, a critical enzyme
of DNA replication (6). In cultured cells, they are most efficiently
induced in breakage by low doses of aphidicolin (APH) treatment,
an inhibitor of DNA polymerase alpha (7). Following such treatment, they become hotspots for sister chromatid exchange, and they
give rise to a high frequency of translocations and deletions (6).

Table 1: Human common fragile sites that have been cloned and their related genes.

Sixteen CFSs have been cloned and characterized at the
molecular level (6). Most lie within or near known genes, and the
two most frequently broken fragile sites in lymphoblasts, FRA3B
and FRA16D, lie within tumor suppressor genes. FRA3B is
centrally located within the FHIT gene, while FRA16D lies within
the WWOX genes (6).
In recent years, their role in the generation of gross
chromosomal rearrangements has become increasingly evident,
and defects in DNA replication, or in the replication checkpoint
greatly increase chromosome instability in cancer cells (7)(10).
The connection between CFSs and cancer thus highlights the
importance of the regulation of DNA replication to prevent cancer
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development (7). A direct involvement of CFSs in cancer has not
been yet established; however, a significant association between
fragile sites and chromosome aberrations found in tumor cells has
been demonstrated (7). Presently, a large consensus agrees that
majority fragile site instability results from cells entering mitosis
before completion of their replication (11), yet the mechanisms
responsible for the delayed replication are still debated (11).

III. Mechanisms of Common Fragile Site Instability
The identiﬁcation of the molecular mechanisms responsible
for instability at fragile sites represents a major challenge (10).
Characterizing these breakage and repair mechanisms may allow
for a better understanding of the causes of genetic mutations that
contribute to cancer.

Secondary Structure Hypothesis
Computational analysis performed on a subset of fragile
site sequences indicated that CFSs containing frequent AT-rich
islands, without any repeat motifs such as expanded trinucleotide
or mini-satellite repeats, may be responsible for the formation of

Figure 1. Formation of secondary structure. A) Low levels of DNA polymerase
contributes to slow replication, leading to long stretches of ssDNA. B) Long ssDNA
eventually self-pairs and forms hairpin loops. C) Hairpin loops either become barriers
that halt replication or result in a cleavage that creates DNA breakage.
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secondary structures (7). This idea has long been a hypothesis
for explaining why CFSs are prone to breaking under conditions
of replication stress (7). With this hypothesis, structures formed
by these sequences stall replication forks, which may lead to
DNA breaks at collapsed replication forks and chromosomal
rearrangements (10). What occurs first is that low levels of DNA
polymerase alpha contribute to a slow replication rate, resulting
in a lagging polymerase complex (10). As a result, replication
polymerase pausing may occur, and long single-stranded DNA
(ssDNA) regions are produced at stalled forks (7). As DNA in this
single-stranded area bends back on itself, a region of sequence
can pair to create secondary structures, such as hairpin loops (10).
Thus, DNA breakage occurs either directly as a result of cleavage
at the site of the secondary structure or as a result that leads to
a stalling of the replication fork, eventually blocking the firing
of new replication origins and preventing entry into mitosis and
promoting repair (Fig. 1.) (7)(10).
It should be noted that recent genome-wide analyses of
CFSs sequences have provided contrasting results regarding the
presence of ﬂexible AT-rich regions within these sites (10). Indeed,
some reports claim that CFSs are highly enriched in ﬂexible ATrich regions, while others fail to identify speciﬁc accumulation of
such sequences in the sites (7)(10). On one side, several analyses
have shown that DNA sequences within or adjacent to deletion
breakpoints contain AT-rich motifs, suggesting that these regions
are prone to breakage (10). On the other side, chromosomes with
deletions that remove AT-rich sequences in FRA16D or FRA3B
still continue to break at the corresponding fragile site (10).

Origin Paucity Hypothesis
Apart from the possibility that CFSs form secondary
structures that may impair replication fork progression, findings
also support a role for replication origin density in determining
the fragility of CFSs (2)(7). Letessier and colleagues state that
due to the scarcity of origins of replications in fragile sites, the
hypothesis of paucity of origins is a causative agent in why CFSs
break. It predicts that fragility is due to two reasons: there are
simply fewer origins prelicensed to be activated, and all available
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origins in the fragile site regions are already activated under
normal growth conditions, so no additional ones can be activated
during times of replication stress (14).
The activity of origins on human chromosomes greatly
differs between cell types, and human CFS instability is correlated
with origin paucity (11). For instance, the human common fragile
sites FRA3B and FRA16D are lacking in origins in lymphoblast
cells and are frequently broken in this cell type (6). Yet in fibroblast
cells, these same fragile sites are not origin-poor and account for
only ~5% of all fragile site breaks (11). Nonetheless, the fact that
both fragile site regions still break at a detectable frequency in
fibroblasts indicates that mechanisms other than origin density are
also likely to contribute to their instability under replication stress.
Thus, the described origin paucity model only partially explains
fragile site instability (11)(14).

Tissue Dependent Hypothesis
Recent mapping of CFSs in different cell types by
conventional and molecular cytogenetic approaches conﬁrmed that
their instability is tissue dependent (10). These results imply that
sequence alone cannot account for CFS instability and raise further
questions of whether any chromosome region can be fragile in one or
another type of tissue (10). Le Tallec and colleagues have examined
a wide variety of fragile sites in lymphocytes, ﬁbroblasts, breast
and colon epithelial cells, and erythroid cells (10). Interestingly,
comparison of these CFSs has revealed that many of these loci are
unstable in several tissues, although their level of fragility could vary
from one cell type to the other (10). Together, these data suggest that
ﬁnite numbers of loci constitute the pool of CFSs and that only a
limited subset of these loci is fragile in a given cell or tissue type (10).

Gene Size Hypothesis
Many CFSs co-map with very large genes, ranging from
600 kb to more than 2 Mb (10). The extensive mapping performed
recently in different human tissue and different species shows
that between 80 and 100% of human CFSs, depending on the cell
type, and 100% of those found in mouse embryonic ﬁbroblast,
are within genes over 300 kb long (10). These genes are at least
15 times larger than the median length of human genes, which
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is approximately 20 kb, and account for approximately 3% of
human genes (10). Notably, CFSs mapped in chicken DT40 cells
also correlate with large genes (10). The most fragile region in
DT40 cells overlaps the large FAM190A and GRID2 genes and is
therefore orthologous to human FRA4F and murine FRA6C1 (10).
These results suggest that the conservation of CFSs in vertebrates
is linked to the conservation of large genes and, conversely, that
chromosome regions containing large genes constitute the pool of
potential CFSs for all cell types (10).
The human genome contains approximately 700 such
genes, sometimes organized in clusters (10). Strikingly, according
to Le Tallec and colleagues, reanalysis of the data provided by two
reports that catalogued focal deletions in cancers and cancer cell
lines has shown that large genes host 51.4% of recurrent deletions
and that many of these genes are associated with CFSs visible in
one or the other tissues in which the sites have now been mapped
(10). These results lead to the conclusion that approximately half
of the recurrent focal deletions found in human cancers originate
from CFSs unstable in the cell types from which the cancers
derive (10).

Transcription Machinery Hypothesis
Recently, it has been proposed that the transcription
process may also contribute to the fragility of CFSs (7). As
previously mentioned, a number of CFSs have been mapped to
the coding regions of large human genes, and it has been well
established that transcription of such genes requires a long time
to be completed, so that transcription and replication may occur
simultaneously (7)(10). Transcription machinery and replication
forks may collide and cause genome stability (7). In a collision,
DNA polymerase inhibits the elongating RNA polymerase
and stable R-loops are created at the site of blockage, thereby
contributing to breakage at long CFS-associated genes (7). It is
important to note, however, that this mechanism cannot justify the
fragility of all the CFSs, as only about half of them are associated
with large genes (7).
Although much progress has been made in understanding
the underlying causes of common fragile site instability, it must be
stated that none of the mechanisms discussed above are mutually
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exclusive, and a clear link between replication process and DNA
breakage at these loci has not been identified (6)(7). A key role seems
to be played by the ability of cells to stabilize stalled forks and to
assure their safe recovery (7). Otherwise, stalled forks could disrupt
replication fork progression, possibly resulting in the formation
of large DNA “unreplicated” regions, which could pose a serious
threat to genome stability (7). More detailed information on how
cells defend themselves against this threat may come from a better
elucidation of mechanisms by which proteins stabilize and/or recover
stalled forks, avoiding degeneration into chromosomal instability (7).

IV. Methods to Study Fragile Site Instability
Yeast
CFSs have been highly conserved throughout mammalian
evolution, where orthologs of human CFSs have been found in
organisms such as primates, cats, dogs, mice, horses, and cows (6).
This evolutionary conservation also extends to lower eukaryotes,
most notably Saccharomyces cerevisiae, or yeast, which allows a
more in-depth study of chromosomal breakage (6).
Though the study of CFSs in their natural context within
human cells allows for relevant research in comparison to using
model organisms, research in S. cerevisiae allows for CFSs regions
to be examined out of context, fundamentally separating structural
and context-based mechanisms of CFS breaks (2)(6). Yeast fragile
sites, in contrast to human fragile sites, are primarily sequence
oriented and do not appear to vary in origin usage (6)(13). Yeast
as an experimental model, due to their small genome size, also
promote the discovery of stalled replication forks by facilitating
the collection of larger data sets. For example, according to the
National Center for Biotechnology Information (NCBI), the
human genome is 3,300 Mb long. If we were to locate human
fragile site FRA3B, which is 1 Mb, in relation to the human
genome, there is only a 0.033% chance of finding the sequence.
In contrast, the smaller 12.4 Mb length of the yeast genome yields
a higher percentage of 8.06% in the location of the fragile site.
Therefore, it is relatively easier to locate the hard sought needle in
a smaller haystack, in comparison to a larger one. Yeast are also
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excellent models to study replications fork collapses that lead to
breakage, using the powerful method of molecular combing.

Molecular Combing
Understanding the mechanisms involved in the initiation
and regulation of DNA replication requires the identification
and characterization of origins of replication (4)(5). Classical
techniques employed to identify origins of replication include
competitive PCR and 2D-gel electrophoresis, which rely on
identifying newly synthesized DNA fragments and threedimensional structures, respectively (4). Molecular combing
represents a powerful, more direct method to study replication
dynamics at the level of single molecules (12). Using this approach,
DNA fibers are stretched and aligned on a glass surface by the force
exerted by a receding air/water interface (12). DNA is consistently
stretched in a uniform manner, and an array with thousands of DNA
molecules is generated (9). Furthermore, because all molecules
are identically stretched, reliable measurements of the replication
units and of their size distributions can be readily obtained (4).
Analysis of the replication signals on a whole genome
basis, issued either from single or sequential labeling, provides
useful parameters for dynamic replication studies (4). For instance,
because the rate of DNA synthesis correlates with fork densities
and distributions, the spatial and temporal organization of DNA
replication can be directly deduced on a genome-wide basis (4).
Moreover, measurements made on an appropriate set of replication
data can reveal the frequency of origin activation during the S phase,
with firing events mapped in time (4)(13). Together, these analyses
might, in turn, reveal correlation between the different parameters
governing DNA replication in a variety of genetic backgrounds (4).
In this manner, a comprehensive understanding of the dynamics of
genome duplication is feasible, making quantitative studies possible
and allowing thoughtful planning of such studies (4)(9).
According to Herrick et al., 1999, the method of DNA
combing was first developed during attempts to speciﬁcally anchor
individual DNA molecules to a solid surface in order to map genetic
alterations in the human genome (12). The simple principle behind
this method involves the physico-chemical binding of the molecules
by one or both of their extremities to a silanized glass coverslip,
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and the uniform alignment and homogenous extension of all
attached molecules (8). DNA combing has been used to study DNA
replication by the direct labeling of replicating DNA sequences using
halogenated thymidine analogs, such as iododeoxyuridine (IdU) and
chlorodeoxyuridine (CldU), allowing origins of replication to be
directly visualized and mapped on a genome wide basis (1)(8)(12).
IdU and CldU are incorporated into a yeast artificial chromosome
during S phase of the cell cycle and base pair with adenine during
their respective 10-minute pulses (6). A later 90-minute pulse of
excess thymidine with nocodazole ensures completion of replication
and prevents entry into another cell cycle (Fig. 3)(6).
Letessier and colleagues used combing to elucidate the
fragility of FRA3B, where interestingly, even though they found
fork symmetry to be greatly increased after aphidicolin treatment
of cells, the stalling showed no difference between the locus and
bulk genome regardless of the growth condition, concluding that
the replication dynamics along FRA3B are not localized to the
FHIT gene (11).
Combing studies of replication in S. cerevisiae are more
complicated, as they are unable to incorporate the thymidine
analogs into their DNA because they lack the nucleotide salvage
pathway that enables the uptake of extracellular thymidine or its
analogs (1). To overcome this limitation, S. cerevisiae strains are
engineered to incorporate IdU and CldU (1). Ectopic incorporation
of the Herpes simplex virus thymidine kinase (HSV-TK) and the
human equilibrative nucleoside transporter 1 (hENT1) have been
shown to improve thymidine uptake and incorporation (1)(12).

DNA Labeling
With different strains and different experiments, the
process of DNA labeling and combing varies. In a typical analysis,
yeast cells are first arrested in G1 phase of the cell cycle with
α-factor pheromone and later released synchronously into S phase
(6)(12). A pulse of IdU is added just before the cells are released
from G1 arrest, and the cells are allowed to grow for ten minutes
(6). The cells are then switched to a medium containing CldU and
allowed to grow for another ten minutes (6). They are subsequently
switched to a 90-minute pulse of excess regular thymidine and
nocodazole, which allows the completion of regular synthesis and
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prevents the cells from entering another cycle of mitosis (12).
DNA is then purified in an agarose plug to limit shearing,
or tearing, and placed into a solution of YOYO-1, zymolyase, and
proteinase (6). YOYO-1 is a florescent dye that binds genomic
DNA and allows for measurement of DNA length, while zymolyase
breaks down the cell wall and proteinase consumes residual proteins
in order to isolate the DNA (6). The DNA solution is combed onto a
coverslip through the combing machine. DNA fibers are attached to
the coverslip by their ends, and then the machine creates an upward
pulling motion of 300 μm a minute (6). DNA fibers are denatured
with NaOH, and after neutralization, IdU and CldU are detected with
monoclonal antibodies and visualized with fluorescent secondary
antibodies (6). Fluorescence in situ hybridization is also used to
detect the fragile site sequence within the yeast, using the Genomic
Morse Code (GMC) strategy (4)(9)(11)(14). As the last step, DNA
fibers are visualized using an epifluorescence microscope that is
coupled to a CCD camera. A visual representation of molecular
combing can be found in Figure 2.

Figure 2. Molecular combing analysis of DNA replication in yeast. (A) Cells are released
synchronously into S phase from an α-factor arrest (G1) in the presence of IdU and CldU to
label newly-synthesized DNA in their respective 10-minute pulses. (B) Cells are harvested
and are embedded into agarose DNA plugs to protect chromosomal DNA from mechanical
shearing during the extraction procedure. (C) DNA staining occurs when a plug is put into
solution with YOYO-1. Zymolyase breaks down cells wall while proteinase consumes
protein to isolate DNA. (D) DNA solution is combed on slides by a combing machine into
single strands of DNA. (E) Incorporated IdU and CldU is detected by immunofluorescence
using a combination of primary and secondary antibodies and through FISH probes that can
determine locations of stalled forks in the fragile site sequence (6).
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Figure 3. Incorporation of IdU and CldU into yeast DNA.“I” and “Cl” designate IdU
and CldU. The lagging and leading are not drawn to scale. (A) Halogenated thymidine
analogs act as regular thymidine, so nucleoside linkages occur between adenine and the
analogs. (B) Chase of regular thymidine ensures completion of synthesis.

Figure 4. Combing analysis of replication along a yeast chromosome. (A) Morse code used for
FISH probes (green bars) organized in 3 motifs (C to E) that identify the locations of stalled
forks in the fragile site sequence. (B) Examples of DNA fibers displaying different replication
tracts (newly synthesized DNA labelled with IdU then CldU, respectively revealed in blue and
red). Arrowheads indicate the direction of fork progression.
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Analysis of Combed DNA Fibers
Replication tracks are examined to determine replication
fork speed, fork stalling, and frequency of initiation and termination
events along a fragile site (6). Replication tracts will be identified
with different fluorescent colors, corresponding to the thymidine
analogs: IdU (blue) and CldU (red) (Fig. 4.). Identification of
stalled replication forks are sites in which replication patterns are
asymmetrical, presenting unequal IdU and CldU tracks (13)(14).
Location of the stalled forks within fragile sites is determined by
FISH probes (green bars) organized in three motifs (C to E) that
identify the fragile site region (Fig. 4.).

CONCLUDING REMARKS
Molecular combing is a versatile new tool with a
wide range of applications (8). In conjunction with other methods,
it is a particularly appealing approach to investigating factors
involved specifying and determining replication dynamics along
yeast fragile sites (8). Combing may also facilitate more speciﬁc
investigations into the role of chromatin structure in mediating
between transcription and replication, the relationships between
DNA repair, recombination, and replication, and the underlying
mechanisms controlling the transition to and progression of DNA
replication through S-phase of the cell cycle (8)(13). A variety
of experiments now underway should conﬁrm the utility and
reliability of molecular combing as a new approach to the study
of DNA replication (8). However, fluorescent signal recognition
and analysis of combed molecules is currently a time-consuming
manual process (9). Nonetheless, this time consumption can be
overcome through the development of recognition and analysis
software tailored for signals on combed DNA (9). Work is currently
being carried out to automate signal recognition and analysis fully,
opening up the possibility for high throughput, large-scale studies
that can shed greater light on the mechanisms that cause genome
instability.
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